Efficacy and tolerability of first line ketogenic diet versus high dose adrenocorticotrophic hormone therapy and infantile spasm syndrome: An open label randomised controlled trial

被引：0
|
作者：
Mahesan, A. [1 ]
Sondhi, V. [2 ]
Agarwala, A. [3 ]
Gupta, K. L. [3 ]
Kamila, G. [1 ]
Jauhari, P. [1 ]
Chakrabarty, B. [1 ]
Pandey, R. M. [4 ]
Gulati, S. [1 ]
机构：
[1] All India Inst Med Sci, Child Neurol Div, Pediat, New Delhi, India
[2] AFMC, Pediat, Pune, Maharashtra, India
[3] All India Inst Med Sci, Senior Dietician, Pediat, New Delhi, India
[4] All India Inst Med Sci, Biostatist, New Delhi, India
来源：
EPILEPSIA | 2024年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
457
引用
收藏
页码：381 / 381
页数：1
相关论文
共 50 条
  • [1] Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial
    Dressler, Anastasia
    Benninger, Franz
    Trimmel-Schwahofer, Petra
    Groeppel, Gudrun
    Porsche, Barbara
    Abraham, Klaus
    Muehlebner, Angelika
    Samueli, Sharon
    Male, Christoph
    Feucht, Martha
    EPILEPSIA, 2019, 60 (03) : 441 - 451
  • [2] Supervised exercise therapy versus usual care for patellofemoral pain syndrome: an open label randomised controlled trial
    van Linschoten, R.
    van Middelkoop, M.
    Berger, M. Y.
    Heintjes, E. M.
    Verhaar, J. A. N.
    Willemsen, S. P.
    Koes, B. W.
    Bierma-Zeinstra, S. M.
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 : 1010 - 1013
  • [3] Comparison of Efficacy and Safety of Low- Versus High-Dose Oral Prednisolone in Infantile Spasm (IS): An Open Label Randomized Controlled Trial at the Children's Hospital & Institute of Child Health, Multan, Pakistan
    Basit, Abdul
    Noreen, Nuzhat
    Saleem, Syed Fawad
    Yousuf, Muhammad
    Zafar, Faisal
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (03)
  • [4] Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial
    Liou, Jyh-Ming
    Chen, Chieh-Chang
    Chen, Mei-Jyh
    Chen, Chien-Chuan
    Chang, Chi-Yang
    Fang, Yu-Jen
    Lee, Ji-Yuh
    Hsu, Shih-Jer
    Luo, Jiing-Chyuan
    Chang, Wen-Hsiung
    Hsu, Yao-Chun
    Tseng, Cheng-Hao
    Tseng, Ping-Huei
    Wang, Hsiu-Po
    Yang, Ueng-Cheng
    Shun, Chia-Tung
    Lin, Jaw-Town
    Lee, Yi-Chia
    Wu, Ming-Shiang
    LANCET, 2013, 381 (9862): : 205 - 213
  • [5] Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
    Rajkumar, S. Vincent
    Jacobus, Susanna
    Callander, Natalie S.
    Fonseca, Rafael
    Vesole, David H.
    Williams, Michael E.
    Abonour, Rafat
    Siegel, David S.
    Katz, Michael
    Greipp, Philip R.
    LANCET ONCOLOGY, 2010, 11 (01): : 29 - 37
  • [6] Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial
    Hutson, Thomas E.
    Lesovoy, Vladimir
    Al-Shukri, Salman
    Stus, Viktor P.
    Lipatov, Oleg N.
    Bair, Angel H.
    Rosbrook, Brad
    Chen, Connie
    Kim, Sinil
    Vogelzang, Nicholas J.
    LANCET ONCOLOGY, 2013, 14 (13): : 1287 - 1294
  • [7] An open-label, multicenter, randomized controlled trial of vonoprazan versus esomeprazole as part of first-line triple therapy for Helicobacter pylori infection
    Tamaki, Hiroyuki
    Morita, Masahiro
    Omura, Akina
    Kubo, Atsushi
    Ogawa, Chikara
    Matsunaka, Toshihiro
    Shibatoge, Mitsushige
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 36 - 36
  • [8] Efficacy and safety of subcutaneous rituximab versus intravenous rituximab for first-line treatment of follicular lymphoma (SABRINA): a randomised, open-label, phase 3 trial
    Davies, Andrew
    Merli, Francesco
    Mihaljevic, Biljana
    Mercadal, Santiago
    Siritanaratkul, Noppadol
    Solal-Celigny, Philippe
    Boehnke, Axel
    Berge, Claude
    Genevray, Magali
    Zharkov, Artem
    Dixon, Mark
    Brewster, Michael
    Barrett, Martin
    MacDonald, David
    LANCET HAEMATOLOGY, 2017, 4 (06): : E272 - E282
  • [9] Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial
    Kim, Nam Hoon
    Lim, Soo
    Kwak, Soo Heon
    Moon, Min Kyong
    Moon, Jun Sung
    Lee, Yong-ho
    Cho, Ho Chan
    Lee, Juneyoung
    Kim, Sin Gon
    BMJ OPEN, 2018, 8 (09):
  • [10] Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial
    Menka Yadav
    Aditi Sinha
    Priyanka Khandelwal
    Pankaj Hari
    Arvind Bagga
    Pediatric Nephrology, 2019, 34 : 829 - 835
12345